3 insiders reported 13 Form 4 transactions for Aardvark Therapeutics, Inc. (AARD) over the past 18 months (most recent 2026-09-11). Recent activity: Sun Nelson (Chief Financial & Operating Officer) Sell 14,754 shares, Sun Nelson (Chief Financial & Operating Officer) Sell 62,000 shares, Lee Tien-Li (Chief Executive Officer) Buy 7,000 shares, Sun Nelson (Chief Financial Officer) Buy 3,000 shares, Lee Tien-Li (Chief Executive Officer) Buy 1,229 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Sun Nelson | Chief Financial & Operating Officer | Sell | 14,754 | $73,779 |
| 2026-09-11 | Sun Nelson | Chief Financial & Operating Officer | Sell | 62,000 | $321,179 |
| 2025-12-12 | Lee Tien-Li | Chief Executive Officer | Buy | 7,000 | $101,430 |
| 2025-12-12 | Sun Nelson | Chief Financial Officer | Buy | 3,000 | $43,200 |
| 2025-10-16 | Lee Tien-Li | Chief Executive Officer | Buy | 1,229 | $5,211 |
| 2025-10-16 | Jones Bryan | Chief Operating Officer | Buy | 1,250 | $5,300 |
| 2025-09-16 | Lee Tien-Li | Chief Executive Officer | Buy | 6,500 | $61,815 |
| 2025-09-16 | Lee Tien-Li | Chief Executive Officer | Buy | 3,500 | $34,790 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 9,000 | $71,190 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 6,000 | $46,920 |
| 2025-09-12 | Lee Tien-Li | Chief Executive Officer | Buy | 5,000 | $42,500 |
| 2025-09-10 | Sun Nelson | Chief Financial Officer | Buy | 6,000 | $48,420 |
| 2025-08-29 | Lee Tien-Li | Chief Executive Officer | Buy | 17,209 | $72,966 |
来源：SEC Form 4 申报文件 · 截至 2026-09-11